is retatrutide or tirzepatide better vs #tirzepatide at a glance… #onthepen Retatrutide vs Tirzepatide | FIRST

In that context, todays move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business

2 In 2024, the approved commercial versions of semaglutide are Ozempic 3-4 , Rybelsus 3,5 , and Wegovy injection 3,6 , developed by Novo Nordisk

Retatrutide 12mg Retatrutide is a cutting-edge triple agonist research peptide that targets three distinct hormonal receptors: GLP-1, GIP, and the glucagon receptor (GCGR)

It contributes to early satiety and weight loss, but also underlies many of the adverse effects and emergency department presentations associated with these medications

However, semaglutides share is projected to decline to 37% by 2035, as tirzepatide emerges as the new market leader

They are the ones to read carefully